Search results
Understanding AKI‐related proteome changes is critical for prevention and development of novel therapeutics to recover kidney function and to mitigate the...
Sehen Sie sich das Profil von Lukas Reiter Lukas Reiter auf LinkedIn, einer professionellen Community mit mehr als 1 Milliarde Mitgliedern, an. Berufserfahrung: Biognosys AG · Ausbildung:...
- University of Zurich
- Biognosys AG
- 1.9K
- Zürich, Schweiz
About. Lukas Reiter is the current Chief Technical Officer at Biognosys. Prior to this, they worked as a trainee at Aebersold Laboratory ETH, where they investigated whether genome annotation could be improved using shotgun proteomic data.
- CTO
- Biognosys, Biognosys
Jul 7, 2023 · Lukas Reiter. CTO at Biognosys AG. Published Jul 7, 2023. + Follow. The recent ASMS conference was a fantastic display of mass spectrometry (MS) advances and a great opportunity to showcase some...
- Lukas Reiter
Tomorrow, Thursday, November 3, 2022, our CTO, Lukas Reiter, PhD, will present during a free webinar on plasma proteomics by The European Proteomics…
Lukas Reiter, PhD. CTO lukas.reiter@biognosys.com www.biognosys.com. • Deep learning augmented directDIA . significantly improves proteome . coverage • To our knowledge the first example of DIA outperforming DDA significantly . (25%) in protein IDs from single shot HeLa acquisitions when searching . with a FASTA file.
In the cohort, we identified 2,732 proteins. Using machine learning, we discovered biomarker candidates such as STAT3 in colorectal cancer and developed models that classify the disease state. For ...
